Hikma’s diversified business delivers resilient H1 performance community news Hikma’s diversified business delivers resilient H1 performance AETOSWire sarjatha 4 August، 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its...Read More